BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

601 related articles for article (PubMed ID: 17875755)

  • 21. High-affinity small molecule inhibitors of T cell costimulation: compounds for immunotherapy.
    Huxley P; Sutton DH; Debnam P; Matthews IR; Brewer JE; Rose J; Trickett M; Williams DD; Andersen TB; Classon BJ
    Chem Biol; 2004 Dec; 11(12):1651-8. PubMed ID: 15610849
    [TBL] [Abstract][Full Text] [Related]  

  • 22. T lymphocyte co-signaling pathways of the B7-CD28 family.
    Wang S; Chen L
    Cell Mol Immunol; 2004 Feb; 1(1):37-42. PubMed ID: 16212919
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Complete rejection of a T-cell lymphoma due to synergism of T-cell receptor costimulatory molecules, CD80, CD40L, and CD40.
    Ruybal P; Gravisaco MJ; Barcala V; Escalada A; Di Sciullo P; Waldner C; Mongini C
    Vaccine; 2008 Jan; 26(5):697-705. PubMed ID: 18155328
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Costimulation of memory T-cells by ICOS: a potential therapeutic target for autoimmunity?
    Sporici RA; Perrin PJ
    Clin Immunol; 2001 Sep; 100(3):263-9. PubMed ID: 11513539
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Costimulation of T cells for tumor immunity.
    Chen L; Linsley PS; Hellström KE
    Immunol Today; 1993 Oct; 14(10):483-6. PubMed ID: 7506034
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Co-inhibitory molecules of the B7-CD28 family in the control of T-cell immunity.
    Chen L
    Nat Rev Immunol; 2004 May; 4(5):336-47. PubMed ID: 15122199
    [No Abstract]   [Full Text] [Related]  

  • 27. B7-H1 blockade augments adoptive T-cell immunotherapy for squamous cell carcinoma.
    Strome SE; Dong H; Tamura H; Voss SG; Flies DB; Tamada K; Salomao D; Cheville J; Hirano F; Lin W; Kasperbauer JL; Ballman KV; Chen L
    Cancer Res; 2003 Oct; 63(19):6501-5. PubMed ID: 14559843
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Regulation of CD28 expression on CD8+ T cells by CTLA-4.
    Berg M; Zavazava N
    J Leukoc Biol; 2008 Apr; 83(4):853-63. PubMed ID: 18162511
    [TBL] [Abstract][Full Text] [Related]  

  • 29. B7-1 gene-modified tumor cell vaccines.
    Antonia SJ
    Curr Opin Mol Ther; 1999 Feb; 1(1):50-6. PubMed ID: 11249684
    [No Abstract]   [Full Text] [Related]  

  • 30. Altered expression of the costimulatory molecules CD80, CD86, CD152, PD-1 and ICOS on T-cells from paracoccidioidomycosis patients: lack of correlation with T-cell hyporesponsiveness.
    Cacere CR; Mendes-Giannini MJ; Fontes CJ; Kono A; Duarte AJ; Benard G
    Clin Immunol; 2008 Nov; 129(2):341-9. PubMed ID: 18757242
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Negative regulators of T-cell activation: potential targets for therapeutic intervention in cancer, autoimmune disease, and persistent infections.
    Pentcheva-Hoang T; Corse E; Allison JP
    Immunol Rev; 2009 May; 229(1):67-87. PubMed ID: 19426215
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Therapeutic opportunities in the B7/CD28 family of ligands and receptors.
    Carreno BM; Carter LL; Collins M
    Curr Opin Pharmacol; 2005 Aug; 5(4):424-30. PubMed ID: 15935730
    [TBL] [Abstract][Full Text] [Related]  

  • 33. EpCAM-specific vaccine response by modified antigen and chimeric costimulatory molecule in cynomolgus monkeys.
    Neighbors M; Apt D; Chang JC; Brinkman A; Sipos-Solman I; Ong R; Leong S; Punnonen J
    J Immunother; 2008 Sep; 31(7):644-55. PubMed ID: 18600180
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Therapeutic peptidomimetic strategies for autoimmune diseases: costimulation blockade.
    Allen SD; Rawale SV; Whitacre CC; Kaumaya PT
    J Pept Res; 2005 Jun; 65(6):591-604. PubMed ID: 15885118
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Teleost B7 expressed on monocytes regulates T cell responses.
    Sugamata R; Suetake H; Kikuchi K; Suzuki Y
    J Immunol; 2009 Jun; 182(11):6799-806. PubMed ID: 19454675
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Inhibitory B7-family molecules in the tumour microenvironment.
    Zou W; Chen L
    Nat Rev Immunol; 2008 Jun; 8(6):467-77. PubMed ID: 18500231
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Feline B7.1 and B7.2 proteins produced from swinepox virus vectors are natively processed and biologically active: potential for use as nonchemical adjuvants.
    Winslow BJ; Kalabat DY; Brown SM; Cochran MD; Collisson EW
    Vet Microbiol; 2005 Nov; 111(1-2):1-13. PubMed ID: 16181751
    [TBL] [Abstract][Full Text] [Related]  

  • 38. B7-2/CD28 costimulatory pathway in children with atopic dermatitis and its connection with immunoglobulin E, intracellular interleukin-4 and interferon-gamma production by T cells during a 1-month follow-up.
    Chernyshov PV
    J Eur Acad Dermatol Venereol; 2009 Jun; 23(6):656-9. PubMed ID: 19250325
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The balance of immune responses: costimulation verse coinhibition.
    Subudhi SK; Alegre ML; Fu YX
    J Mol Med (Berl); 2005 Mar; 83(3):193-202. PubMed ID: 15630593
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Evaluation of CD86/CD28 and CD40/CD154 pathways in regulating monocyte-derived CD80 expression during their interaction with allogeneic endothelium.
    Wang P; Liu Z; Wu C; Zhu B; Wang Y; Xu H
    Transplant Proc; 2008 Oct; 40(8):2729-33. PubMed ID: 18929847
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 31.